Literature DB >> 21336725

Inhibitory effect of endostar in combination with radiotherapy in a mouse model of human CNE2 nasopharyngeal carcinoma.

Ning Zhou1, Guangyuan Hu1, Qi Mei1, Hong Qiu1, Guoxian Long1, Chunli Chen1, Hu Guoqing2.   

Abstract

The inhibitory effects of Endostar in combination with radiotherapy in BALB/c nude mice model of human CNE2 nasopharyngeal carcinoma and the mechanism were investigated. In nude mice model of CNE2 nasopharyngeal carcinoma, the inhibitory rate and the sensitizing enhancement ratio (E/O) were calculated according to the tumor volumes in different groups. The expression of microvascular density (MVD) in tumor tissues was examined by using immunohistochemistry staining. The transcription of VEGF gene was detected by using RT-PCR. The inhibitory rate in Endostar+ radiotherapy group was higher than in other groups. In Endostar+radiotherapy group, the tumor volume was significantly decreased and the E/O ratio was 2.335, suggesting that Endostar could be a radiosensitizer. The expression of MVD of tumor tissues in Endostar+radiotherapy group was reduced significantly. The expression of the MVD in treatment groups was significantly different from that in control group (P<0.05). Compared to other groups, VEGF mRNA expression in Endostar+radiotherapy group was decreased remarkably. Endostar in combination with radiotherapy significantly inhibited the growth of CNE2 tumor. The combination therapy decreased the expression of VEGF, and inhibited tumor angiogenesis and proliferation. When combined with radiotherapy, Endostar acted as a radiosensitizer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336725     DOI: 10.1007/s11596-011-0151-7

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  16 in total

1.  Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model.

Authors:  Xian Luo; James M Slater; Daila S Gridley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-01       Impact factor: 7.038

2.  Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors.

Authors:  Malin Sund; Yuki Hamano; Hikaru Sugimoto; Akulapalli Sudhakar; Mary Soubasakos; Udaya Yerramalla; Laura E Benjamin; Jack Lawler; Mark Kieran; Amish Shah; Raghu Kalluri
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

3.  Effects of protein and gene transfer of the angiopoietin-1 fibrinogen-like receptor-binding domain on endothelial and vessel organization.

Authors:  Cornelia C Weber; Hao Cai; Martin Ehrbar; Hisashi Kubota; Georg Martiny-Baron; Wilfried Weber; Valentin Djonov; Ernst Weber; Ajit S Mallik; Martin Fussenegger; Karl Frei; Jeffrey A Hubbell; Andreas H Zisch
Journal:  J Biol Chem       Date:  2005-03-21       Impact factor: 5.157

Review 4.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

5.  Openings between defective endothelial cells explain tumor vessel leakiness.

Authors:  H Hashizume; P Baluk; S Morikawa; J W McLean; G Thurston; S Roberge; R K Jain; D M McDonald
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

6.  Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans.

Authors:  Renata C M Reis; Detlef Schuppan; Aline C Barreto; Michael Bauer; Jens P Bork; Gerda Hassler; Tatiana Coelho-Sampaio
Journal:  Biochem Biophys Res Commun       Date:  2005-08-05       Impact factor: 3.575

7.  Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.

Authors:  C G Lee; M Heijn; E di Tomaso; G Griffon-Etienne; M Ancukiewicz; C Koike; K R Park; N Ferrara; R K Jain; H D Suit; Y Boucher
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

8.  Combined effects of angiostatin and ionizing radiation in antitumour therapy.

Authors:  H J Mauceri; N N Hanna; M A Beckett; D H Gorski; M J Staba; K A Stellato; K Bigelow; R Heimann; S Gately; M Dhanabal; G A Soff; V P Sukhatme; D W Kufe; R R Weichselbaum
Journal:  Nature       Date:  1998-07-16       Impact factor: 49.962

9.  Gene therapy delivery of endostatin enhances the treatment efficacy of radiation.

Authors:  Wenyin Shi; Christian Teschendorf; Nicholas Muzyczka; Dietmar W Siemann
Journal:  Radiother Oncol       Date:  2003-01       Impact factor: 6.280

10.  Radiation and endostatin gene therapy in a lung carcinoma model: pilot data on cells and cytokines that affect angiogenesis and immune status.

Authors:  Xian Luo; James M Slater; Daila S Gridley
Journal:  Technol Cancer Res Treat       Date:  2006-04
View more
  4 in total

1.  The inhibitory effects of Endostar combined with chemotherapy on human esophageal squamous cell carcinoma xenograft in mice.

Authors:  Liang Chang; Fengjie Guo; Yalei Lv; Yudong Wang; Bingjie Huo; Long Wang; Wei Liu
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

Review 2.  Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma.

Authors:  Zhuo Chen; Xin-Hua Xu
Journal:  Saudi Med J       Date:  2015-06       Impact factor: 1.484

3.  Recombined humanized endostatin (Endostar) intravenous infusion in the treatment of refractory nasopharyngeal carcinoma: Three case reports.

Authors:  Chen Chen; Song-Ran Liu; Shu Zhou; Xiao-Hui Li; Xiao-Hui Wang; Ya-Lan Tao; Hui Chang; Wen-Wen Zhang; Wen-Fei Li; Si-Lang Zhou; Yun-Fei Xia
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

4.  Contrast-enhanced ultrasound analysis of tissue perfusion in tumor-bearing mice following treatment with endostatin combined with radiotherapy.

Authors:  Wei Ge; Yongfa Zheng; Zezhang Tao
Journal:  Exp Ther Med       Date:  2014-02-28       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.